Introducing the Merck MyChoice™ Card
TORONTO, Oct. 7, 2013 /CNW/ - Innovators of the Canadian patient choice
assistance card program, RxHelp™, today announced a new card that will
help thousands of Canadian patients prescribed certain Merck
prescription medications stay on their preferred brands. The new Merck
MyChoice™ card covers up to the cost difference between fourteen leading Merck
brand prescription medicines and the generic version right at the
Without the use of a patient choice card like the Merck MyChoice™ card, Canadians may have their prescriptions filled with a generic
version of the brand name medicine originally prescribed by their
doctor. However, now patients with prescriptions for Andriol®, Cosopt®, Elocom®, Maxalt®, Maxalt® RPD, Marvelon®, Nasonex®, Propecia®, Proscar®, Sinemet®, Sinemet® CR, Singulair®, Timoptic® XE, Trusopt® are eligible to use the Merck MyChoice™ card.
Patients understand the importance of maintaining consistency in the
brand of medication they take in order to achieve the best treatment
outcomes. The Merck MyChoice™ card helps patients maintain an active role in their healthcare and
allows them the choice to have their prescription filled with the brand
name medication prescribed by their doctor.
Whether it be a woman choosing to stay on Marvelon® for her family planning needs or an allergy or migraine sufferer
wanting to remain on brand name Singulair®, Nasonex® or Maxalt® -- The Merck MyChoice™ card is the new card helping patients who choose to stay on their
brand name medication.
"RxHelp™ is pleased to have introduced patient choice programs to
Canadian patients," says Craig Martin, President, RxHelp.ca. "Programs
like the Merck MyChoice™ Program supports patients' choice to continue on their brand name
medications. We are proud to be offering the Merck MyChoice™ Card and are excited about what this one card means for Canadian
patients, physicians and pharmacists alike. Staying on brand name
doesn't have to cost you more."
What are the benefits of the Merck MyChoice™ card?
Patients: The Merck MyChoice™ card makes it easier for patients on multiple Merck brands to remain
on their preferred brand name medications
Pharmacists: The card makes it easier for pharmacists as they only need one card to
use for the participating Merck brands, per patient
Physicians: Will find it easier as they only need to store and hand out one
How does it work?
Patients present a valid prescription for a Merck brand available on
this program, along with the Merck MyChoice™ Card to their pharmacist and ask for their brand name medicine to be
dispensed. The Merck MyChoice™ card will pay up to the difference between the amount the patient
would otherwise have to pay at the pharmacy for the Merck medication,
and the amount the patient would have to pay for the generic. The
Merck MyChoice™ Card and other RxHelp Patient Choice cards can be used at any Canadian
Cards are free and can also be downloaded to a smart phone or printed as
a PDF from www.RxHelp.ca. Cards can also be ordered by calling 1-866-RxHelp4
(1-866-794-3574). Cards are free of charge; there are no hidden fees,
no monthly charges and patient privacy is protected.
RxHelp.ca is a patient-centric service offered by leading Canadian
research-based pharmaceutical companies and managed by
Toronto-headquartered Cameron Stewart LifeScience. Founded in 2006,
Cameron Stewart LifeScience is a communications and consulting firm
that specializes in healthcare and pharmaceutical marketing and is an
industry leader in patient choice/assistance programs.
The RxHelp™ Patient Choice card allows consumers to remain on their brand name
medicines at little or no additional cost over the generic version. A
patient must have a valid prescription from their doctor, present it
along with a corresponding RxHelp™ Patient Choice card to their pharmacist and request to remain on their
brand. A complete list of all medications offered on the RxHelp™ card can be found at www.RxHelp.
For further information:
For more information on RxHelp™ or to coordinate an interview, please contact: